Business · 01/10/2019

FDA Clears KENALOG Ointment for Continued Sale

The US Food and Drug Administration (FDA) has ruled that KENALOG (Triamcinolone Acetonide) ointment, 0.025% and 0.1%, and other related drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing them to remain on the market.